Are you and your team focusing on manufacturing efficiency, solid tumor durability, accessibility, safety, cost-efficiency, product release times, autoimmune indications, armoring, potency assays, resistance or investment for your cell therapy pipelines this year? The 9th CAR-TCR Summit agenda has been created in collaboration with the cell...